BeStock  
Stocks › Biotechnology › GENB

Generate Biomedicines GENB

US equityMarket cap rank #2863Biotechnology
$13.91 +$0.22 (+1.61%)
Pre-market · Oct 6, 4:10 am ET · After hours $13.94 +0.20%
Open$13.71
Prev close$13.69
Day range$13.45 – $14.06
Volume1.12M
Market cap$1.79B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / sales67.4x
CheapRich

Above its usual level · 69th percentile, 5-year average 60.0x

#4878 of 5147 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$23.88
Price vs. fair value-41.8%Trading below the estimate
Star rating★★★★★
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PS 67.42 88.60 60.04 69% (pricier than usual) #4878 of 5147 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★★
Fair value estimate$23.88
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on GENB.

Leave a comment

Scroll to Top